帕金森病患者白内障手术的麻醉考虑:叙述性综述
Alyssa Chiew1, David Mathew1, Chandra M Kumar1
1Department of Anaesthesia, Khoo Teck Puat Hospital, Yishun, Singapore.
Anesthesiology and pain medicine
|November 29, 2023
概括
帕金森病 (PD) 患者需要仔细的麻醉管理眼科手术,如白内障手术由于潜在的并发症. 本综述总结了在这些手术期间安全管理PD患者的关键麻醉考虑因素.
科学领域:
- 神经学 神经学
- 麻醉学 麻醉学
- 眼科医生 眼科 眼科
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,影响运动控制和认知功能.
- 在接受眼科手术的PD患者的麻醉管理缺乏具体指导方针.
- 由于自主功能障碍和药物相互作用,PD带来了独特的挑战.
研究的目的:
- 审查和总结对接受白内障手术的帕金森病患者麻醉方面的考虑.
- 为在眼科中为PD患者制定麻醉指南提供基础.
主要方法:
- 这项研究是对现有文献的叙述性审查.
- 确定并综合了相关的研究和指导方针.
主要成果:
- 麻醉管理需要仔细考虑PD药物,潜在的药物相互作用和定位.
- 区域麻醉可能是首选的,以尽量减少系统性影响,但全身麻醉可以使用修改.
- 监测自主性不稳定性和术后并发症至关重要.
结论:
- 针对性麻醉计划对于接受白内障手术的帕金森病患者至关重要.
- 需要进一步的研究,以建立基于证据的指导方针,以此种人群的麻醉护理.
相关概念视频
General Anesthesia: Overview
Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Stages of General Anesthesia
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...


